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Hippo signaling controls organ size and tissue regen-
eration in many organs, but its roles in chondrocyte
differentiation and bone repair remain elusive. Here,
we demonstrate that Yap1, an effector of Hippo
pathway inhibits skeletal development, postnatal
growth, and bone repair. We show that Yap1 regu-
lates chondrocyte differentiation at multiple steps
in which it promotes early chondrocyte proliferation
but inhibits subsequent chondrocyte maturation
both in vitro and in vivo. Mechanistically, we find
that Yap1 requires Teads binding for direct regulation
of Sox6 expression to promote chondrocyte prolifer-
ation. In contrast, Yap1 inhibits chondrocyte matura-
tion by suppression of Col10a1 expression through
interaction with Runx2. In addition, Yap1 also gov-
erns the initiation of fracture repair by inhibition of
cartilaginous callus tissue formation. Taken together,
our work provides insights into the mechanism by
which Yap1 regulates endochondral ossification,
which may help the development of therapeutic
treatment for bone regeneration.
INTRODUCTION
Endochondral ossification is an important process for both skel-
etal development and bone repair. In the long bones, cartilage
anlage is first formed by mesenchymal condensation, followed
by chondrocyte differentiation and maturation and subsequently
bone mineralization (Kronenberg, 2003). Similarly, bone repair2224 Cell Reports 14, 2224–2237, March 8, 2016 ª2016 The Authorsemploys similarmechanism to regenerate newbone tissues after
injury (Bolander, 1992; Bruder et al., 1994; Deschaseaux et al.,
2009; Einhorn, 1998; Ferguson et al., 1999; Wang and Boyapati,
2006). For instance, during fracture healing, mesenchymal stem
cells (MSCs) migrate to the wound site and differentiate into
chondroblasts and chondrocytes. These cells then undergo pro-
liferation, hypertrophy, and mineralization to form cartilaginous
callus tissues. New bone is then deposited, and the process is
completed through bone remodeling that restores normal shape
and function of the bones. These sequential steps are concom-
itantly regulated by key transcription factors that are highly
conserved during skeletal development. Sox9 is a major regu-
lator for early chondrogenesis (Lefebvre and de Crombrugghe,
1998). It promotes chondrocyte differentiation and cooperatively
interacts with transcriptional factors Sox5 and Sox6 for chondro-
cyte proliferation and differentiation (Akiyama et al., 2002; Smits
et al., 2001). Chondrocyte matrix components such as Aggrecan
and Col2a1 are then sequentially expressed (Han and Lefebvre,
2008; Lefebvre et al., 1998).Runx2, amajor regulator of chondro-
cyte hypertrophy (Takeda et al., 2001), subsequently expressed
and regulates the expression of its target genes such asCol10a1
for successive chondrocyte maturation (Zheng et al., 2003).
Many signaling pathways are implicated in the chondrocyte dif-
ferentiation process to tightly regulate the pace of cartilage and
bone formation during skeletal development and fracture heal-
ing. For instance, Ihh (Vortkamp et al., 1998), Pth (Ellegaard
et al., 2010), Bmp (Tsuji et al., 2006), and Wnt/b-catenin (Huang
et al., 2012) signaling all contribute to both processes. However,
bone repair is not as efficient as skeletal development by activa-
tion of these pathways suggesting that the regulatory mecha-
nisms for these processes are more complicated than expected
and additional signaling interactions may be involved for the
process.
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Figure 1. Yap1 Expression Is Gradually Reduced during Chondrocyte Differentiation
(A) Yap1 was expressed in the growth plates of wild-type tibias at E14.5 (n = 3 per group) as shown by immunofluorescence (RZ, resting chondrocytes; PZ,
proliferative chondrocytes; PHZ, prehypertrophic chondrocytes; HZ, hypertrophic chondrocytes). Scale bars, 100 mm. See also Figure S1.
(B) Micromass culture from chondroprogenitor cells isolated from E12.5 wild-type embryos. Cultures were stained with Alcian blue (A.B.) and Safranin O (S.O.)
solution as shown.
(C and D) Gene expression analysis of micromass culture from (B).
(E) Protein analysis of micromass culture from (B). The experiment was repeated three times independently. Error bars represent SD.Hippo signaling controls organ size (Pan, 2007; Song et al.,
2010; Wu et al., 2003; Zhou et al., 2009) and tissue regeneration
inmany organs (Heallen et al., 2013; Karpowicz et al., 2010; Zhao
et al., 2011). Central to this pathway is a kinase cascade consist-
ing of Mst1/2, Sav, Lats1/2, and Mats in the mammalian system.
When the Hippo signaling is active, a series of phosphorylation
events via Msts and Lats kinases occurs and ultimately leads
to the phosphorylation of Yap1, a key effector of the pathway
(Halder and Johnson, 2011; Pan, 2010; Zhao et al., 2010). Phos-
phorylated Yap1 is sequestered in the cytoplasm, which inhibits
its transcriptional activity. In contrast, inactivation of the Hippo
pathway increases Yap1 nuclear translocation. It then interacts
with Tead/Tef family transcription factors to activate Hippo
target genes that are responsible for cell proliferation and
apoptosis. Other than Teads, it has been recently shown that
Yap1 is also able to interact withmany other transcription factors
for the crosstalk with different signaling pathways (Alarco´n et al.,
2009; Espanel and Sudol, 2001; Fernandez-L et al., 2009; Rose-
nbluh et al., 2012), suggesting that Yap1 serves as a regulator to
integrate multiple signaling cascades during many biological
processes. In the context of the bone, Zaidi et al. previously
showed that Yap1mediated by Src/Yes tyrosine kinase signaling
interacts with Runx2 to regulate Osteocalcin expression (Zaidi
et al., 2004). In vitro studies also demonstrate that Yap1 inhibits
osteogenesis from bone-marrow-derived MSCs (Seo et al.,
2013). In contrast, high Yap1 activities in MSCs promote osteo-Cegenesis (Dupont et al., 2011). However, whether Hippo signaling
or Yap1 regulates chondrocyte differentiation and bone repair
remain largely unclear.
Here, we investigated the roles of Yap1 in regulating chondro-
cyte differentiation and maturation during skeletal development,
postnatal growth, and bone repair. We found that Yap1 pro-
motes early chondrocyte proliferation but inhibits chondrocyte
hypertrophy andmaturation both in vitro and in vivo, but its effect
is more pronounced during bone repair. Specifically, Yap1 atten-
uates endochondral ossification during both skeletal develop-
ment and fracture healing. Our findings provide insights into
the regulatory mechanisms in chondrocyte differentiation for
bone formation and repair.
RESULTS
Yap1 Expression Gradually Reduces during
Chondrocyte Differentiation
To study the roles of Yap1 during skeletal development, we first
examined the endogenous expression pattern of Yap1 in the
long bones during endochondral bone formation. In the growth
plates of mouse embryos, we found that Yap1 was expressed
in resting and proliferative chondrocytes but less in hypertrophic
chondrocytes at E14.5 (Figures 1A and S1). In contrast, the
expression of phosphorylated Yap1 was strongest in the hyper-
trophic chondrocytes where Col10a1 and Runx2 expressionll Reports 14, 2224–2237, March 8, 2016 ª2016 The Authors 2225
were detected. It suggests that Yap1 activity was gradually
reduced during chondrocyte maturation. We also performed mi-
cromass culture using chondroprogenitor cells isolated from the
limb buds of E12.5 wild-type embryos (Figure 1B). During chon-
drocyte differentiation, chondrocyte markers such as Col2a1,
Ihh, and Col10a1 were increased and peaked at around day 5
to day 7 and then gradually reduced thereafter (Figure 1C).
Runx2 expression was peaked at day 10. Interestingly, Yap1
expression was gradually reduced along with cartilage nodule
formation while the expression level of phosphorylated Yap1
was gradually increased (Figures 1D and 1E). These expression
patterns were consistent with the expressions observed in the
growth plates. We also examined the expression pattern of
Yap1 paralog Taz (Figure 1E). However, its expression was grad-
ually increased during cartilage nodule formation in micromass
culture, which was opposite to that of total Yap1 expression.
Altogether, both in vivo and in vitro data suggest that Yap1 plays
a functional role in regulating chondrocyte differentiation.
Yap1 Inhibits Skeletal Development and Postnatal
Growth
To examine the functional roles of Yap1 in vivo, we generated
transgenic mice in which Yap1 was overexpressed in chondro-
cytes as well as osteoprogenitor cells under the control of
Col2a1 promoter and enhancer (Long et al., 2001). Two trans-
genic lines (TG01 and TG02) were generated (Figure S2A), and
both of them showed Yap1 overexpression in all chondrocytes,
but not other tissues being tested (Figures S2B–S2E). Since
TG01 displayed a higher level of Yap1 expression and therefore
it was selected for subsequent analyses and named as Col2a1-
Yap1tg/+. Surprisingly, the Col2a1-Yap1tg/+ transgenic mice
showed mild skeletal abnormalities at birth with the skeleton of
normal size and shape as compared to that of the control litter-
mates (Figure 2A), suggesting that endochondral bone formation
was largely unaffected. The subtle phenotypes during early skel-
etal development suggest that the developing skeleton is either
insensitive to Yap1 overexpression or the overexpression level of
Yap1 is not strong enough. We therefore further increased Yap1
overexpression by self-crossing the Col2a1-Yap1tg/+ transgenic
line to generate a homozygousCol2a1-Yap1tg/tg transgenic mice
(Figure S2F). The transgene copy number was doubled in the
homozygous transgenic mice (Figure S2G), and the expression
of Yap1 in chondrocytes was much stronger than that of the het-
erozygous Col2a1-Yap1tg/+ transgenic mice (Figures S2H–S2J)
while the expression of Taz was unaffected (Figure S2H). Inter-
estingly, only homozygous Col2a1-Yap1tg/tg transgenic chon-
drocytes showed a significant upregulation of Hippo target
genes Cyr61 and Ctgf, albeit a trend of increase expression
was observed in the heterozygous group (Figures S2I and
S2J). This may explain the mild skeletal phenotypes observed
in the Col2a1-Yap1tg/+ transgenic mice. The homozygous
Col2a1-Yap1tg/tg transgenic mice displayed a markedly smaller
skeleton size than that of the heterozygous transgenic mice (Fig-
ure 2A). Close histologic examination of the long bones revealed
that all the chondrocyte zones were present in the transgenic
groups and the overall length of the growth plates was progres-
sively shorter with increasing Yap1 overexpression (Figure 2B).
Similar results were observed in the vertebral columns (Fig-2226 Cell Reports 14, 2224–2237, March 8, 2016 ª2016 The Authorsure S2K). Next, we examined the maturation of terminally differ-
entiated hypertrophic chondrocytes by von Kossa staining (Fig-
ures 2C and S2L). Both the growth plates from the long bones
and the vertebral columns displayed reduction of mineralization
of hypertrophic chondrocytes at the chondro-osseous junctions.
Consistently both Col10a1 and Mmp13 expression were also
reduced in the long bone sections (Figures 2D and 2E). These
data suggest that chondrocyte hypertrophy was delayed in vivo
and that Yap1 inhibits chondrocyte maturation during skeletal
development.
We asked whether postnatal skeletal growth of the Col2a1-
Yap1 transgenic mice was also affected. We observed that the
secondary ossification center in the long bones of the Col2a1-
Yap1tg/tg transgenic mice was delayed starting from 1 week of
age (Figure 2F). Subchondral bone region was also significantly
smaller at 4 weeks old (Figure 2G). The overall bone mass
accrual was significantly lower when compared with their age-
matched wild-type littermates (Figures 2H and 2I). However,
we cannot exclude the possibility that the phenotypes may be
also in part contributed by osteoblasts as Col2a1+ cells also ex-
pressed in early perichondrium. Altogether, our data suggest
that Yap1 inhibits endochondral ossification during skeletal
development and growth.
To examine whether Yap1 is required for skeletal development
and bone growth, we generated Yap1c/c;Col2a1-Cre mutant
mice. Skeletal preparation at both E16.5 and E18.5 showed
that the Yap1c/c;Col2a1-Cre mutant mice was slightly bigger in
size than that of the age-matched wild-type littermates (Figures
3A–3H). Mild increases of mineralized tissues were observed.
Histologic examinations revealed that the mutant growth plates
were progressively longer than that of the controls with age (Fig-
ures 3I, 3K, and 3M). The expression of hypertrophic markers
Col10a1 and Runx2 were increased in the mutant growth plates
(Figure 3J), and mineralization was also significantly increased
as revealed by von Kossa staining (Figures 3L and 3N). These
data mirrored the phenotypes of the Col2a1-Yap1tg/tg transgenic
mice. Altogether, our data strongly indicate that Yap1 inhibits
chondrocyte maturation and endochondral ossification during
bone development.
Yap1 Promotes Early Chondroprogenitor Cell
Proliferation
To investigate the mechanistic actions of Yap1 during chondro-
cyte differentiation and maturation, we first examined its roles in
early events of chondrogenesis by manipulating Yap1 expres-
sion in MSCs isolated from mouse bone marrows with lentivi-
ruses (Figures S3A–S3C). The proliferation rate of MSCs was
greatly increased when Yap1 was overexpressed for 72 hr as re-
vealed by MTT assay (Figure 4A). Colony formation assay also
showed a significant increase of the number of colonies (Figures
4B and 4C). Gene expression of stemness markers such as
Sox2, Pou5f1, and Klf4 were all significantly upregulated (Fig-
ure 4D). In contrast, knockdown of Yap1 displayedmirror pheno-
types of the overexpression studies (Figures 4E–4H). We also
performed the colony formation assay using chondroprogenitor
cell line ATDC5, and consistent results were obtained (Figures
S3D and S3E). These results indicate that Yap1 is required for
chondroprogenitor cell proliferation and maintenance. Similarly,
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Figure 2. Skeletal Abnormalities of Col2a1-Yap1 Transgenic Mice
(A) Skeletal preparations of newborn mice (n = 3 per group) with respective genotypes at postnatal day 1 as shown. Forelimb and hind limb are shown in the lower
panel with higher magnification. See also Figure S2.
(B) Growth plate sections of the tibia of respective mice (n = 6 per group) at day 1 as shown by Safranin O staining. Scale bars, 250 mm. See also Figures S2K
and S2L.
(C) Terminally differentiated hypertrophic chondrocytes in tibias of respective mice (n = 6 per group) are shown by von Kossa staining at day 1. Boxed areas
showed the regions with reduction of calcification of terminally differentiated hypertrophic chondrocytes in the transgenic groups. Scale bars, 250 mm.
(D and E) Immunohistochemistry of tibial growth plates of (D) Col10a1 and (E) Mmp13 expression of respective mice (n = 3 per group) as shown. Boxed region
showed higher magnification of expression patterns. Scale bars, 250 mm.
(F) Safranin O staining of femoral secondary ossification centers at day 10 of mice with respective genotypes as shown. Scale bars, 500 mm (upper panel); 250 mm
(lower panel). Arrows point to the regions of secondary ossification centers.
(G) Tibial subchondral bone regions of respective genotypes as shown by Safranin O staining at day 28 (n = 3 per group). The length of the epiphysis was indicated
by black bars. Scale bars, 500 mm (upper panel); 250 mm (lower panel).
(H) 3D micro-CT images of the femur of 10-week-old mice (n = 3 per group). Scale bars, 1 mm.
(I) Histomorphometric analysis of bone parameters in the femur of mice in (H). Error bars represent SD (***p < 0.001).knockdown of Taz also showed consistent results in cell prolifer-
ation and colony formation as in Yap1 knockdown (Figures S3F–
S3K). It suggests that both Yap1 and Taz play similar roles in
regulating early chondroprogenitor cell proliferation. In addition,
Yap1c/c;Prx1-Cre mutant mice, in which Yap1 was removed in
early limb bud mesenchyme, also displayed a significant smaller
skeleton (Figures S3L–S3N). This is mainly a consequence of
reduced proliferation of early chondroprogenitor cells. TakenCetogether, our data indicate that Yap1 plays a positive role in regu-
lating early chondroprogenitor cell proliferation.
Yap1Promotes Chondrocyte Proliferation by Regulation
of Sox6 Expression through Teads Binding
Next, we investigate the roles of Yap1 in chondrocyte pro-
liferation by examining phosphohistone-3 (PH-3) expression in
the Col2a1-Yap1 transgenic mice. Interestingly, chondrocytell Reports 14, 2224–2237, March 8, 2016 ª2016 The Authors 2227
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Figure 3. Skeletal Phenotypes of Yap1c/c;
Col2a1-Cre Mutant Mice
(A–H) Skeletal preparations of mice at (A–D) E16.5
and (E–H) E18.5 with genotypes as shown. Arrows
and black bars show regions with increased
mineralization. Scale bars, 5 mm for the whole
skeleton; 1 mm for individual region.
(I–N) Tibial growth plates of (I)–(J) at E15.5, (K)–(L)
E16.5, and (M) and (N) E18.5 with genotypes as
shown. Scale bars, 250 mm (I, K, and N); 100 mm (J);
and 200 mm (L and M).proliferation was increased in the growth plates of both trans-
genic groups (Figures 5A and 5B). Similar results were obtained
in the primary chondrocytes isolated from the transgenic mice as
well (Figures 5C and 5D). To understand the targets regulated by
Yap1 during chondrocyte proliferation, we search for genes
involved in the regulation of chondrocyte proliferation.Sox6 is re-
ported to be responsible for regulating chondrocyte proliferation
(Smits et al., 2001), and we foundmultiple tentative Tead binding
sites in the promoter region of Sox6 (Figure 5E). Teads are tran-
scriptional factors required for Yap1 binding to DNA (Vassilev
et al., 2001). We therefore performed chromatin immunoprecip-
itation (ChIP) assay using primary chondrocytes isolated from
the Col2a1-Yap1tg/+ transgenic mice. DNA of the specific Tead
binding regions was amplified after immunoprecipitation with
Yap1 antibodies. A strong PCR bandwas detected in the BS2 re-
gion of the Sox6 promoter (Figure 5F), suggesting that Yap1/
Teads complexes induce Sox6 expression. To confirm this
finding, we examined Sox6 expression in the Col2a1-Yap1tg/+
transgenic chondrocytes isolated from the growth plates of the
long bones. As expected, transgenic chondrocytes displayed
strong upregulation of Sox6 expression (Figure S4A). Similarly,
we overexpressed Yap1 in primary chondrocytes and found
that the expression of Sox6 was upregulated (Figure 5G). In2228 Cell Reports 14, 2224–2237, March 8, 2016 ª2016 The Authorscontrast, knockdown of Yap1 resulted
in a significant reduction of Sox6 expres-
sion (Figure 5H). Furthermore, dual lucif-
erase assay using reporter plasmids with
promoter region 1.2 kb upstream of the
transcription start site of Sox6 showed
consistent results with both Yap1 overex-
pression and knockdown studies (Figures
5I–5J). Knockdown of Sox6 in primary
chondrocyte of Col2a1-Yap1tg/+ trans-
genic mice (Figure S4B) displayed signifi-
cantly reduced chondrocyte proliferation
(Figures 5K and S4C). Similarly, knock-
down of Yap1 also showed reduced chon-
drocyte proliferation (Figures 5L, S4D, and
S4E). However, when Sox6 was overex-
pressed, the reduced chondrocyte prolif-
eration was rescued to a similar level as
in the control. These findings indicate
that Yap1 mediates its effect at least in
part through Sox6 in promoting chondro-
cyte proliferation.In order to test whether the effect of Yap1 on Sox6 expression
is dependent on Teads binding, we overexpressed a mouse
Yap1S79A mutant (same mutation as human Yap1S94A) in
chondrocytes in which the binding site with Teads was mutated.
The effects of Yap1 on Sox6 expression were abolished in both
the RNA and protein levels when mutant Yap1S79A was ex-
pressed (Figures 5M, 5N, and S4F). Dual luciferase assay using
the same Sox6 reporter plasmids also showed a significant
reduction of luciferase activities similar to the background level
(Figure 5O). In addition, ChIP assay revealed that the enrichment
of BS2 region of the Sox6 promoter was significantly reduced
with Yap1S79A (Figure 5P). These data indicate that Teads bind-
ing is necessary for Yap1 to regulate Sox6 expression. Collec-
tively, our results indicate that Yap1 promotes early chondrocyte
proliferation through regulation of Sox6 expression in a Teads-
dependent manner.
Yap1 Inhibits Chondrocyte Maturation by Regulation of
Col10a1 Expression through Runx2 Interaction
Although early cell proliferation was increased by Yap1 overex-
pression, the growth plates of Col2a1-Yap1 transgenic groups
were significantly smaller as compared to their respective con-
trols suggesting that chondrocyte maturation was remarkably
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Figure 4. Yap1 Promotes Chondroprogenitor Cell Proliferation and Is Required for Its Maintenance
(A) Cell proliferation rate of bone marrow MSCs as shown by MTT assay after 72 hr. See also Figure S3.
(B) Colony formation assay of mouse bone marrow MSCs as shown by crystal violet staining.
(C) Statistical analysis of colony numbers from (B).
(D) Gene expression analysis using samples from (A).
(E) Cell proliferation rate of bone marrow MSCs with shYap1 lentiviruses as shown by MTT assay.
(F) Colony formation assay with shYap1.
(G) Statistical analysis of (F).
(H) Gene expression analysis using samples from (E). The qRT-PCR analysis was performed in triplicates and repeated three times independently.
Error bars represent SD (**p < 0.01; *p < 0.05).impaired. To further confirm the phenotypes, we isolated limb
bud cells from the Col2a1-Yap1tg/+ transgenic embryos and
performed micromass culture. We found that cartilage nodule
formation and maturation was greatly delayed at day 7 (Fig-
ure S5A). The delay was more pronounced at day 14. Gene
expression of Col2a1, Aggrecan, and Col10a1 were all signifi-
cantly downregulated (Figure S5B) indicating that chondrocyte
maturation was inhibited. Micromass culture using wild-type
limb bud cells with Yap1 adenovirus infection showed similar re-
sults (Figures 6A, 6B, S5C, and S5D). In contrast, knockdown of
Yap1 increased cartilage nodule formation, and all chondrocyte
markers being examined were upregulated (Figures 6C and 6D).
Consistently, micromass culture using ATDC5 cell line also
showed similar results (Figures S5E–S5H). Taken together, our
results indicate that Yap1 inhibits chondrocyte differentiation
and maturation both in vivo and in vitro. However, knockdown
of Taz in micromass culture showed slower maturation (Fig-
ure S5I). Chondrocyte maturation markers were all downregu-
lated in micromass culture as well as in primary chondrocytes
with shTaz transduction (Figures S5J and S5K). In contrast, Taz
overexpression in primary chondrocytes increased their expres-
sions (Figure S5L). These data indicate that Yap1 and Taz func-
tion paradoxically opposite with each other in regulating chon-
drocyte maturation.
To identify the mechanistic roles of Yap1 in inhibiting chondro-
cyte maturation, we first examined the expression of hypertro-
phic marker Col10a1. We found that overexpression of Yap1 inCeprimary chondrocytes inhibited Col10a1 expression (Figure 6E),
which was consistent with our in vivo results (Figure 2D). In
contrast, knockdown of Yap1 relieved the suppression of
Col10a1 expression (Figure 6F). It has been previously reported
that Runx2 is a key regulator for Col10a1 expression and chon-
drocyte hypertrophy (Takeda et al., 2001) in which Runx2 pro-
motes Col10a1 expression (Figure 6G). Thus, we overexpressed
Yap1 in the presence of Runx2 in primary chondrocytes to
examine the changes of Col10a1 expression (Figure 6H). Similar
to previous observations, Yap1 overexpression inhibited Runx2-
induced Co10a1 expression. Next, we cloned a 1.5-kb promoter
region upstream of the transcription start site of Col10a1 to
the luciferase reporter plasmids for dual luciferase assay. We
showed that Runx2 expression resulted in a dose-dependent
increase of the luciferase activities in our Co10a1 reporter plas-
mids in wild-type primary chondrocytes (Figure 6I). In agreement
with our previous results, Yap1 overexpression in primary chon-
drocytes inhibited luciferase activities of Col10a1, while knock-
down of Yap1 enhanced it (Figure 6J). When we co-transfected
Runx2 with Yap1, the Runx2-induced luciferase activities of
Col10a1 was suppressed (Figure 6K). Further increase of Yap1
expression revealed a dose-dependent inhibitory effect (Fig-
ure 6L). In contrast, when Yap1 was knocked down, the
Col10a1 luciferase activities were further enhanced as com-
pared to the Runx2 alone group (Figure 6K). Similarly, we
repeated these experiments using 293T cell lines and consistent
results were obtained (Figures S6A and S6B). Furthermore,ll Reports 14, 2224–2237, March 8, 2016 ª2016 The Authors 2229
increased expression of Runx2 was able to rescue the inhibitory
effects of Yap1 (Figure S6C). We also showed that Runx2 co-
localized with Yap1 in primary chondrocytes (Figure 6M). Immu-
noprecipitation with Yap1 antibodies also displayed positive
interaction of Runx2 in primary chondrocytes (Figure 6N). Recip-
rocally, pull-down of Runx2 revealed a positive interaction with
Yap1 (Figure 6O). Next, we determined whether the binding of
Runx2 with Yap1 requires Teads. Interestingly, immunoprecipi-
tation assay showed that Tead1 overexpression significantly
reduced the binding of Yap1 with Runx2 (Figure S6D). This sug-
gests that Runx2 competes with Teads for Yap1 interaction
duringmaturation. We further performed a ChIP assay in the pro-
moter region of Col10a1 where three Runx2 binding sites were
found (Figure 6P) (Li et al., 2011; Zheng et al., 2003). ChIP assay
using Runx2 antibodies revealed that Yap1 overexpression
reduced the enrichment of PCR bands in BS-2 and BS-3 (Fig-
ure 6Q). It suggests that Yap1 competes for Runx2 and releasing
Runx2 from chromatin. Interestingly, increasing expression of
Taz progressively induced the luciferase activities of Col10a1 in
the presence of Runx2 (Figure S6E), which is in sharp contrast
to Yap1 function. Overexpression of Taz also enhanced the bind-
ing of Runx2 to BS-1 domain of the Col10a1 promoter region
(Figure 6Q). All these data indicate that Taz competes with
Yap1 for Runx2 interaction in order to modulate the expression
of Col10a1 to control chondrocyte maturation. Altogether, our
data indicate that Yap1 inhibits chondrocyte maturation by regu-
lating Col10a1 expression through interaction with Runx2.
Yap1 Overexpression or Inactivation of Hippo Signaling
Impairs Cartilaginous Callus Formation during Bone
Repair
To gain further insights of Yap1 in postnatal skeletal function and
given that appropriate and controlled chondrocyte maturation
play fundamental roles in the initial steps of bone repair, we
therefore created standardized fractures in the Col2a1-Yap1tg/+
transgenic mice and the Mst1c/c; Mst2c/c; Dermo1-Cre mutant
mice, respectively (Figure 7). Both Mst1 and Mst2 kinases
were genetically removed simultaneously at very early limb
mesenchyme using Dermo1-Cre mouse line (Yu et al., 2003)
that resulted in Yap1 activation as shown by reduced phosphor-
ylated Yap1 (Figure S7A). Consistent with the Col2a1-Yap1tg/+
transgenic mice, cell proliferation was significantly increased in
theMst1c/c; Mst2c/c chondrocytes after Cre adenovirus infection
(Figures S7B and S7C). Mild delayed of chondrocyte hypertro-
phy was observed in the long bones of the Mst1c/c; Mst2c/c;
Dermo1-Cremutant mice (Figures S7D and S7E). All the skeletal
phenotypes in the Mst1c/c; Mst2c/c; Dermo1-Cre mutant mice
strongly resembled to the heterozygous Col2a1-Yap1tg/+ trans-
genic mice. Thus, we used both animal models to study bone
repair. Two weeks after fracture injury, radiographs from wild-
type mice showed obvious callus formation at the site of fracture
with significant amount of cartilage formation (Figures 7A, 7B,
7G, and 7H). However, cartilaginous callus formation in the
Col2a1-Yap1tg/+ transgenic mice and the Mst1c/c; Mst2c/c;
Dermo1-Cre mutant mice were significantly impaired (Figures
7A, 7B, 7G, and 7H). Only a residual amount of chondrocytes
were observed as shown by Safranin O staining. Micro-CT ana-
lyses further revealed that both bone volume and bone surface of2230 Cell Reports 14, 2224–2237, March 8, 2016 ª2016 The Authorsthe callus tissues were significantly reduced (Figures 7E, 7F, 7J,
and 7K). Histological sections showed that transgenic chondro-
cytes were less mature than that of the wild-type control as re-
vealed by less Safranin O staining intensity (Figure 7B) and less
proteoglycan contents as revealed by reduction of Aggrecan
expression (Figure 7D). Sox9 expression level was largely un-
changed in both immunohistochemistry and qRT-PCR analyses,
but Col2a1 and Col10a1 expression was significantly reduced
(Figures 7C and 7D). Similar gene expression pattern was
also observed in the callus tissues isolated from the Mst1c/c;
Mst2c/c; Dermo1-Cre mutant mice (Figure 7I), and the pheno-
types were generally more severe as compared to that of the
Col2a1-Yap1tg/+ transgenic mice. Collectively, our data indicate
that fracture healing is greatly impaired with Yap1 overexpres-
sion due to early inhibition of cartilaginous callus formation dur-
ing endochondral ossification.
DISCUSSION
Here, we present mechanistic functions of Yap1 in regulating
chondrocyte differentiation during skeletal development, post-
natal growth, and fracture repair. We found that Yap1 regulates
multiple steps in the chondrocyte lineage in which Yap1 pro-
motes early chondrocyte proliferation but inhibits subsequent
chondrocyte maturation. As a result, endochondral ossification
is inhibited. Strikingly, bone repair is remarkably impaired that
most of the chondrocytes are maintained at an immature state
in the cartilaginous callus tissues.
It is interesting that the function of Yap1 in bone repair
is much more significant than that of skeletal development
and skeletal growth because the bone fracture phenotypes
were already very obvious when using the heterozygous
Col2a1-Yap1tg/+ transgenic mice. In contrast, only homozygous
Col2a1-Yap1tg/tg transgenic mice demonstrated severe bone
defects during skeletal development and growth. These results
indicate that Yap1 plays a more prominent role during bone
regeneration and repair. The discrepancies of the phenotypes
of Yap1 overexpression between bone repair and skeletal devel-
opment can be reconciled by the fact that many other signaling
pathways are highly active during embryonic bone development
(Long and Ornitz, 2013). For instance, Ihh and Pthlh signaling
(St-Jacques et al., 1999; Vortkamp et al., 1996) play major roles
to control the pace of chondrocyte proliferation, hypertrophy,
and maturation during endochondral bone formation. However,
these signaling activities gradually reduce after birth (Mak
et al., 2008a; Tsukazaki et al., 1995). In contrast, the expression
and activities of Hippo core components such as Lats and Msts
gradually increase along with bonematuration (Song et al., 2012)
suggesting that Hippo signaling is more important in regulating
adult bone homeostasis. Consistently, we also observed that
endogenous expression of Yap1 is reduced after birth (Fig-
ure 1B). Thus, Mst kinases should be constitutively active to sup-
press Yap1 functions in postnatal bone homeostasis. Therefore,
overexpression of Yap1 during bone repair resulted in a more
pronounced phenotype than that of skeletal development.
In fact, the overall inhibitory function of Yap1 in skeletal devel-
opment and callus formation is somewhat paradoxical to its role
in promoting cell growth and survival as in many soft tissues as
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Figure 5. Sox6 Is a Direct Target of Yap1 in Promoting Chondrocyte Proliferation
(A) Fluorescent immunohistochemistry of phosphohistone-3 (PH3) of tibial growth plates of respective mice at day 1 as shown (n = 3 per group). Scale bars,
250 mm.
(B) Statistical analysis of PH3 positive cells in (A).
(C) PH3 staining using primary chondrocytes isolated from respective mice as shown. Scale bars, 50 mm.
(D) Statistical analysis of PH3 positive cells in (C).
(E) Schematic diagram of tentative Teads binding sites in the Sox6 promoter (TSS, transcription start site; BS, binding site).
(legend continued on next page)
Cell Reports 14, 2224–2237, March 8, 2016 ª2016 The Authors 2231
well as during tumorigenesis. We demonstrate that Yap1 pro-
motes early chondrocyte proliferation, which is consistent to its
known functions as in other cell contexts in soft tissues. How-
ever, the increase of extracellular matrix (ECM) stiffness in carti-
lage tissues may affect the functional outcomes mediated by
Yap1. It has been reported that ECM stiffness regulates Yap1 ac-
tivity (Dupont et al., 2011) and Yap1 is also required for cell-cell
contact inhibition (Zhao et al., 2007). The highly rigid skeletal
environment may therefore interfere with the cellular responses
of Yap1 activities, which results in different phenotypic out-
comes in the skeletal tissues, which lead to inhibition of chondro-
cyte maturation. In addition, previous study also demonstrates
that Yap1 can function as a suppressor ofOsteocalcin activation
in osseous cells (Zaidi et al., 2004). Given the highly related
lineages of chondrocytes and osteoblasts in the skeletal system,
it is not surprising that Yap1 employs similar mechanisms in
regulating chondrocyte maturation by suppression of Col10a1
expression. However, the upstream signaling cascades that
regulate Yap1 activities are different. Our work here demon-
strates a possible role of Hippo pathway mediated by Yap1 in
chondrocyte differentiation because the Mst1c/c; Mst2c/c;
Dermo1-Cre mutant mice also display similar phenotypes as
the Col2a1-Yap1tg/+ transgenic mice. However, the phenotypes
from the Mst1c/c; Mst2c/c; Dermo1-Cre mutant mice was more
severe, which can be accounted for by the fact that not only
chondrocyte lineage was being affected, but Mst1/2 inactivation
in the osteoblast lineage may also have contributed to the
phenotypes.
Apart from chondrocyte differentiation, Yap1 also determines
alternate cell-fate choices between osteogenesis and adipogen-
esis from MSCs (Seo et al., 2013). Both Yap1 knockdown and
Yap1 overexpression impair adipogenesis. However, Yap1 over-
expression blocks osteogenesis through binding to b-catenin
and induces Wnt antagonist Dkk1. In line with this, our work
here also demonstrates that the level of Yap1 has to be exqui-
sitely controlled in the chondrocyte lineage for proper chondro-
cyte differentiation since Yap1 regulates both chondrocyte pro-
liferation and hypertrophy simultaneously. It is important to
note that, other than Yap1, its close paralog Taz is also an
effector of Hippo pathway. Taz co-activates Runx2-dependent
gene transcription to promote osteogenesis and suppresses
Pparg to inhibit adipogenesis (Cui et al., 2003; Hong et al.,
2005). We showed that Taz similarly promotes chondroprogeni-
tor cell proliferation as Yap1. However, Taz function in opposite
with Yap1 in regulating chondrocyte maturation. It remains un-
clear how Hippo signaling precisely coordinates the differential
effects of Yap1 and Taz in the regulation of chondro, osteo,(F) ChIP assay using primary chondrocytes isolated from theCol2a1-Yap1tg/+ tran
tentative Teads binding sites of the promoters as shown in (E). See also Figure S
(G and H) Sox6 expression in primary chondrocytes with (G) Yap1 overexpressio
(I and J) Dual luciferase assay of Sox6 activities using reporter plasmids of Sox6
Yap1 knockdown.
(K) Statistical analysis of cell proliferation in Col2a1-Yap1 chondrocytes after Sox
(L) Statistical analysis of chondrocyte proliferation with Yap1 knockdown and So
(M and N) RNA (M) and protein (N) analysis of Sox6 expression with wild-type m
(O) Luciferase analysis with Yap1(S79A).
(P) ChIP assay with Yap1(S79A) expression. Samples were collected in triplicate
Error bars represent SD (***p < 0.001; **p < 0.01; *p < 0.05).
2232 Cell Reports 14, 2224–2237, March 8, 2016 ª2016 The Authorsand adipo lineages. It is interesting to further investigate the
interplay between Yap1 and Taz in regulating cell-fate commit-
ment. To conclude, our work identifies mechanistic functions
of Yap1 in regulating chondrocyte differentiation and, in partic-
ular, its prominent effect during bone repair, which may be impli-
cated for the development of therapeutics for fracture healing.
EXPERIMENTAL PROCEDURES
Generation of Mouse Strains
TheMst1 (Lu et al., 2010; Song et al., 2010),Mst2 (Lu et al., 2010; Song et al.,
2010), Yap1 (Xin et al., 2011; Zhang et al., 2010), Col2a1-Cre (Ovchinnikov
et al., 2000), and Dermo1-Cre (Yu et al., 2003) mouse lines have been
described previously. Col2a1-Yap1tg/+ transgenic lines were generated
(C57Bl6 3 CBA) using Col2a1 promoter and enhancer as described (Long
et al., 2001). Full-length mouse Yap1 cDNA (isform2) was cloned under the
control of the Col2a1 promoter and enhancer. Two independent transgenic
lines were generated by pronuclear injection. The line TG01 with the highest
expression of Yap1 in the cartilage was selected for most of the studies. Ho-
mozygous Col2a1-Yap1tg/tg transgenic line was generated by self-crossing
TG01 heterozygous transgenic mice, which gave rise to a more severe pheno-
type. Genotyping was done by PCR using genomic DNA isolated from the tail
tips. All animal experiments were performed according to procedures
approved by the Animal Experimentation Ethics Committee of the Chinese
University of Hong Kong.
Plasmid Construction
Full-length mouse Yap1 cDNA (isform2) was subcloned into pFLAG (pCMV-
Tag 2C, Stratagene), pCDH (pCDH-CMV-MCS, SBI System Biosciences),
pEGFP-C1 (Invitrogen), and pAd Track (pAdTrack-CMV, Addgene) vectors,
respectively. Full-length Taz and Runx2 were subcloned into pFLAG (pCMV-
Tag 2C, Stratagene). Full-length Sox6 and Tead1 were subcloned into
pCDNA3.1 Myc-His(–) (Invitrogen) vectors. For shRNA plasmid construction,
two different pairs of oligos containing complementary hairpin sequences
were synthesized and cloned into pLV-3 (pGLVH1/GFP+Puro, GenePharma)
lentiviral vector. The targeted sequences for Yap1 gene were 50-GGCAA
TACGGAATATCAAT-30 and 50-GCGCTGAGTTCCGAAATCT-30, respectively.
Skeletal Preparation, X-Ray Analyses and Micro-computed
Tomography Analysis
Embryos and newborns were skinned, eviscerated, and fixed in 4% parafor-
maldehyde. Skeletal preparation was performed as described (McLeod,
1980). For X-ray analyses, mice were anesthetized and radiographed using
the Faxitron MX-20 Digital machine (Faxitron X-Ray) at 32 kV for 6,000 ms. Mi-
cro-CT analyses were performed using mCT40 (Scanco Medical) with a reso-
lution of 8 mm isometric voxel with 70 kV and 114 mA. Three-dimensional
(3D) reconstruction was performed for the regions of interest (ROIs) and sub-
jected to bone microarchitecture and mineral density analyses using built-in
software from Scanco Medical and published protocol (Zhang et al., 2012).
Bone Fracture Model
Unilateral fractures were produced in the right femora as previously described
(Lindsey et al., 2010). Briefly, the mice were anesthetized and the hindquartersgenic mice. PCRwas performed using primers (F1-R1 and F2-R2) flanking the
4.
n or (H) Yap1 knockdown.
promoter (1.2 kb) in primary chondrocytes with (I) Yap1 overexpression and (J)
6 knockdown.
x6 overexpression.
ouse Yap1 and Yap1(S79A).
s, and three independent experiments were performed.
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Figure 6. Yap1 Inhibits Chondrocyte Maturation by Regulating Col10a1 Expression
(A) Micromass culture using limb buds isolated from wild-type mice at E12.5 with Yap1 overexpression (A.B., Alcian blue; S.O., Safranin O; A.R.S., Alizarin Red S
staining). See also Figure S5.
(B) Gene expression analysis using RNA isolated at day 7 from (A).
(C) Micromass culture of with Yap1 knockdown.
(D) Gene expression analysis using RNA isolated at day 7 from (C).
(E and F) Col10a1 expression in primary chondrocytes with Yap1 manipulation as shown.
(G) Col10a1 expression in primary chondrocytes with Runx2 overexpression.
(H–L) Dual luciferase assay of Col10a1 activities using reporter plasmids with 1.5-kb Col10a1 promoter region in primary chondrocytes. See also Figure S6.
(M) Immunofluorescence of primary chondrocytes with Yap1 (green) and Runx2 (red). Scale bar, 30 mm.
(N and O) Immunoprecipitation analysis with (N) Yap1 antibodies and (O) anti-Flag antibodies for pull-down of Runx2 in primary chondrocytes.
(P) Schematic diagram of Runx2 binding domains in the Col10a1 promoter (TSS, transcription start site; BS, binding site).
(Q) ChIP assay in primary chondrocytes using Runx2 antibodies. Each assay was performed in triplicates and repeated for three times independently.
Error bars represent SD (***p < 0.001; **p < 0.01; *p < 0.05).
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Figure 7. Fracture Healing Is Impaired in the Col2a1-Yap1tg/+ Transgenic Mice and the Mst1c/c; Mst2c/c; Dermo1-Cre Mutant Mice
(A) X-ray analysis of fractured femora of 3-month-old transgenic mice 2 weeks after fracture injury on the right hind limbs (n = 6 per group). White arrows point to
the fracture site where soft callus tissues formed. See also Figure S7.
(B) Safranin O staining of the fracture sites at 2 weeks after injury (n = 6 per group). Scale bars, 1,000 mm (left panel); 60 mm (right panel).
(C) Immunohistochemistry of chondrocyte markers in the callus tissues of respective mice (n = 3 per group) 2 weeks after fracture injuries as shown. Scale bars,
60 mm.
(D) Gene expression analysis using tissues isolated from (B). qRT-PCR analysis was performed in triplicates and repeated three times independently.
(E) 3D micro-CT images of the callus tissues at the fracture sites 4 weeks after surgery (n = 3 per group). Scale bars, 1 mm.
(F) Microarchitecture analysis of bone parameters from (E).
(G–K) Similar analysis using the Mst1c/c; Mst2c/c; Dermo1-Cre mutant mice as shown in (A)–(F).
Error bars represent SD (***p < 0.001; **p < 0.01; *p < 0.05; NS, not significant).
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was shaved. The leg was fractured using a blunted blade placed at the mid-
shaft of the femur. Following fracture, an incision wasmade on the dorsolateral
surface of the femur from the area of the greater trochanter to the epicondyles
of the femur through the gluteus superficialis. The two ends of the fractured fe-
mur were fixed using a 23G needle. The wound was closed using Polysorb for
myofascial closure and staples for skin closure. The animals were randomly
assigned to surgical groups, but they were not conducted in a completely
blinded fashion. We surgically fractured 12-week-old female wild-type mice,
age- and sex-matched Col2a1-Yap1tg/+ transgenic mice, and Mst1c/c;
Mst2c/c; Dermo1-Cre mutant mice, respectively, for bone repair analyses.
The fracture protocol was approved according to the Animals Ordinance
Chapter 340 ([13-392] in DH/HA&P/8/2/1 Pt.32)). At 2 weeks post-operation,
mice were anesthetized and radiographed to examine cartilaginous callus for-
mation. Six mice per group were used for X-ray and histological analyses,
respectively. Three mice per group were used for RNA extraction and gene
expression analyses. At 4 weeks post-operation, three mice per group were
used for micro-CT analyses.
Histological Analyses and Western Blots
Primary antibodies used in immunohistochemistry and immunofluorescence
include Phospho-histone H3 (PH3) antibodies (Santa Cruz Biotechnology,
sc-8656-R) at 1:100, Yap1 antibodies (Cell Signaling Technology, 4912s) at
1:50, p-Yap1 antibodies (Cell Signal, 4911s) at 1:50, Sox9 antibodies (Abcam,
ab3697) at 1:50, Col2a1 antibodies (Santa Cruz, sc-28887) at 1:100, Mmp13
antibodies (Abcam, ab39012) at 1:50, Col10a1 antibodies (Abcam, ab58632)
at 1:50 and Runx2 antibodies (Cell Signal, 8486S) at 1:50. The immunohisto-
chemistry was performed using Histostain-Plus IHC kit (Invitrogen) following
the manufacturer’s protocol. For western blot analysis, b-Actin antibodies
(Santa Cruz, sc-130656) at 1:2,000 were used for normalization, Yap1 anti-
bodies (Cell Signal, 4912s) at 1:1000, p-Yap1 antibodies (Cell Signal, 4911s)
at 1:1,000, Runx2 antibodies (Cell Signal, 8486S) at 1:1000, Taz antibodies
(BD Pharmingen, 560235) at 1:1,000, and GFP antibodies (Abcam, ab290) at
1:2,000 were used. Procedures were followed as previously described (Topol
et al., 2003). Anti-Flag M2 affinity gel (Sigma, A2220) was used for
immunoprecipitation.
Colony Formation Assay
5,000 cells were seeded in 60-mm culture dish and cultured for 5 days. Crystal
violet staining was performed for counting the colony number. Triplicate plates
were counted.
Micromass Culture and Isolation of Primary Chondrocytes
Micromass cultures were performed as previously described (Guo et al., 2004).
Yap1 adenovirus was used to infect the cells for at least 4 hr before seeding
into culture wells. GFP-adenovirus was used for comparison. Primary chon-
drocytes were isolated from the ventral parts of the rib cages of 0- to 3-day-
old wild-type and transgenic pups as described (Mak et al., 2008b).
Chromatin Immunoprecipitation
Primary chondrocytes (13 107 cells) were fixed with 1% formaldehyde directly
in culture medium at 37C for 10 min. Cells were subsequently quenched by
glycine with final concentration of 125 mM for 5 min at room temperature.
Cells were washed and lysed before sonication. Samples were sonicated for
ten cycles of 10 s each to generate an average DNA fragment size of about
500 bp. Immunoprecipitation was performed following standard protocols as
described previously (Nelson et al., 2006) with Yap1 antibodies (Cell Signal,
4912s) at 1:100, Runx2 antibodies (Cell Signal, 8486S) at 1:100 or 5 mg rabbit
normal immunoglobulin G (IgG) (Cell Signal, 2729). ChIP grade protein A/G
agarose was used (Thermo Scientific, 26159).
RNA Isolation and qRT-PCR
Total RNA was isolated using the TRIzol reagent (Invitrogen) according to the
manufacturer’s instructions. Reverse transcription was performed using
M-MLV reverse Transcriptase (Invitrogen). qPCR was carried out using a Plat-
inum SYBR Green kit (Applied Biosystems). Samples were normalized with
Gapdh. Fold difference was determined by 2-DDCT methods.CeDual Luciferase Assay
Primary chondrocytes were transfected with either pGL3-basic, pGL3-Sox6
(1.2 kb), or pGL3-Col10a1 (1.5 kb) luciferase reporters together with Flag-
con, Flag-Yap1, Flag-Runx2, Flag-Taz, shneg, or shYap1 using Lipofectamine
3000 (Invitrogen). pRL-TK vector (Promega) withRenillawas co-transfected as
reference controls. Cells were subjected to luciferase activity measurement as
described in dual luciferase reporter assay kit (Promega).
Statistical Analyses
Two-tailed Student’s t test was used for comparison between two groups as
shown by brackets. Results are represented as mean ± SD. p values <0.05
were considered to be significant. No significant differences in variance be-
tween groups were detected. All analyses were performed with GraphPad
Prism software (v.5.0). No statistical methodwas used to predetermine sample
size. The inclusion criteria were the appropriate genotype of the mice.SUPPLEMENTAL INFORMATION
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